Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An open label study of the pharmacokinetics, safety and antiviral activity of Invirase boosted with ritonavir in HIV-infected infants and children 4 months to <6 years old.

Trial Profile

An open label study of the pharmacokinetics, safety and antiviral activity of Invirase boosted with ritonavir in HIV-infected infants and children 4 months to <6 years old.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Mar 2016

At a glance

  • Drugs Saquinavir (Primary) ; Ritonavir
  • Indications HIV-1 infections
  • Focus Pharmacokinetics
  • Sponsors Roche
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 12 Jul 2011 New source identified and integrated (European Clinical Trials Database record, EudraCT2007-004617-34).
    • 17 Aug 2010 Actual end date changed from May 2010 to Jun 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top